Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 29

Cited In for PubMed (Select 16386793)

1.

The local complement activation on vascular bed of patients with systemic sclerosis: a hypothesis-generating study.

Scambi C, Ugolini S, Jokiranta TS, De Franceschi L, Bortolami O, La Verde V, Guarini P, Caramaschi P, Ravagnani V, Martignoni G, Colato C, Pedron S, Benedetti F, Sorio M, Poli F, Biasi D.

PLoS One. 2015 Feb 6;10(2):e0114856. doi: 10.1371/journal.pone.0114856. eCollection 2015.

2.

Atypical hemolytic uremic syndrome post-kidney transplantation: two case reports and review of the literature.

Alasfar S, Alachkar N.

Front Med (Lausanne). 2014 Dec 12;1:52. doi: 10.3389/fmed.2014.00052. eCollection 2014. Review.

3.

A novel antibody against human properdin inhibits the alternative complement system and specifically detects properdin from blood samples.

Pauly D, Nagel BM, Reinders J, Killian T, Wulf M, Ackermann S, Ehrenstein B, Zipfel PF, Skerka C, Weber BH.

PLoS One. 2014 May 5;9(5):e96371. doi: 10.1371/journal.pone.0096371. eCollection 2014.

4.

Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations.

Salvadori M, Bertoni E.

World J Nephrol. 2013 Aug 6;2(3):56-76. doi: 10.5527/wjn.v2.i3.56. Review.

5.

Atypical hemolytic uremic syndrome.

Kavanagh D, Goodship TH, Richards A.

Semin Nephrol. 2013 Nov;33(6):508-30. doi: 10.1016/j.semnephrol.2013.08.003. Review.

6.

Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease.

Cooper DN, Krawczak M, Polychronakos C, Tyler-Smith C, Kehrer-Sawatzki H.

Hum Genet. 2013 Oct;132(10):1077-130. doi: 10.1007/s00439-013-1331-2. Epub 2013 Jul 3. Review.

7.

Complement therapy in atypical haemolytic uraemic syndrome (aHUS).

Wong EK, Goodship TH, Kavanagh D.

Mol Immunol. 2013 Dec 15;56(3):199-212. doi: 10.1016/j.molimm.2013.05.224. Epub 2013 Jun 28. Review.

8.

Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.

Bresin E, Rurali E, Caprioli J, Sanchez-Corral P, Fremeaux-Bacchi V, Rodriguez de Cordoba S, Pinto S, Goodship TH, Alberti M, Ribes D, Valoti E, Remuzzi G, Noris M; European Working Party on Complement Genetics in Renal Diseases.

J Am Soc Nephrol. 2013 Feb;24(3):475-86. doi: 10.1681/ASN.2012090884. Epub 2013 Feb 21.

9.

Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults.

Fremeaux-Bacchi V, Fakhouri F, Garnier A, Bienaimé F, Dragon-Durey MA, Ngo S, Moulin B, Servais A, Provot F, Rostaing L, Burtey S, Niaudet P, Deschênes G, Lebranchu Y, Zuber J, Loirat C.

Clin J Am Soc Nephrol. 2013 Apr;8(4):554-62. doi: 10.2215/CJN.04760512. Epub 2013 Jan 10.

10.

Familial atypical hemolytic uremic syndrome: a review of its genetic and clinical aspects.

Bu F, Borsa N, Gianluigi A, Smith RJ.

Clin Dev Immunol. 2012;2012:370426. doi: 10.1155/2012/370426. Epub 2012 Nov 8. Review.

11.

Thrombotic microangiopathy and associated renal disorders.

Barbour T, Johnson S, Cohney S, Hughes P.

Nephrol Dial Transplant. 2012 Jul;27(7):2673-85. doi: 10.1093/ndt/gfs279. Review.

12.

Atypical hemolytic uremic syndrome.

Loirat C, Frémeaux-Bacchi V.

Orphanet J Rare Dis. 2011 Sep 8;6:60. doi: 10.1186/1750-1172-6-60. Review.

13.

Complement-mediated injury and protection of endothelium: lessons from atypical haemolytic uraemic syndrome.

Kerr H, Richards A.

Immunobiology. 2012 Feb;217(2):195-203. doi: 10.1016/j.imbio.2011.07.028. Epub 2011 Jul 30. Review.

14.

The development of atypical hemolytic uremic syndrome depends on complement C5.

de Jorge EG, Macor P, Paixão-Cavalcante D, Rose KL, Tedesco F, Cook HT, Botto M, Pickering MC.

J Am Soc Nephrol. 2011 Jan;22(1):137-45. doi: 10.1681/ASN.2010050451. Epub 2010 Dec 9.

15.

Variant-specific quantification of factor H in plasma identifies null alleles associated with atypical hemolytic uremic syndrome.

Hakobyan S, Tortajada A, Harris CL, de Córdoba SR, Morgan BP.

Kidney Int. 2010 Oct;78(8):782-8. doi: 10.1038/ki.2010.275. Epub 2010 Aug 11.

16.

aHUS caused by complement dysregulation: new therapies on the horizon.

Waters AM, Licht C.

Pediatr Nephrol. 2011 Jan;26(1):41-57. doi: 10.1007/s00467-010-1556-4. Epub 2010 Jun 18. Review. Erratum in: Pediatr Nephrol. 2013 Jan;28(1):165.

17.

Genetics and complement in atypical HUS.

Kavanagh D, Goodship T.

Pediatr Nephrol. 2010 Dec;25(12):2431-42. doi: 10.1007/s00467-010-1555-5. Epub 2010 Jun 6. Review.

18.

The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome.

Ferreira VP, Herbert AP, Cortés C, McKee KA, Blaum BS, Esswein ST, Uhrín D, Barlow PN, Pangburn MK, Kavanagh D.

J Immunol. 2009 Jun 1;182(11):7009-18. doi: 10.4049/jimmunol.0804031.

19.

Lack of association between polymorphisms in C4b-binding protein and atypical haemolytic uraemic syndrome in the Spanish population.

Martínez-Barricarte R, Goicoechea de Jorge E, Montes T, Layana AG, Rodríguez de Córdoba S.

Clin Exp Immunol. 2009 Jan;155(1):59-64. doi: 10.1111/j.1365-2249.2008.03798.x.

20.

Shiga toxin-2 results in renal tubular injury but not thrombotic microangiopathy in heterozygous factor H-deficient mice.

Paixão-Cavalcante D, Botto M, Cook HT, Pickering MC.

Clin Exp Immunol. 2009 Feb;155(2):339-47. doi: 10.1111/j.1365-2249.2008.03826.x.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk